期刊名称：DESIDOC Journal of Library & Information Technology
电子版ISSN：0976-4658
出版年度：2012
卷号：32
期号：3
DOI：10.14429/djlit.32.3.2379
语种：English
出版社：DESIDOC, Ministry of Defence, India
摘要：The Indian pharmaceutical industry (IPI) has been largely influenced by the changes in the patent regimesin India. This paper, besides reviewing the evolution of IPI, studies the trends of research and development(R&D) and patenting of pharmaceutical firms and identifies the determinants of R&D. It examines theinterdependence between R&D and patenting, and firms’ overall performance. Secondary data analysis indicatesthat the product patent regime has impacted the R&D intensity of IPI firms. The analysis of primary datacollected from 64 pharmaceutical firms identifies three distinct clusters of firms of IPI. The firms’ performance,measured by the rate of capital employed by the three groups of firms, indicates that superior R&D and a largenumber of patent filings need not necessarily imply a better performance. The paper adds to the extantliterature on IPI by bringing forth implications which are important for formulating appropriate action plans toenable pharmaceutical firms to efficiently employ their resources in the product patent era.http://dx.doi.org/10.14429/djlit.32.3.2379
关键词：Indian pharmaceutical industry; patents; patent regime; Tobit; ROCE; cluster analysis; return on capital employed
Loading...
